News

Proteomics International Laboratories (ASX:PIQ) receives $1.2 million R&D incentive – The Market Herald

Study results have shown PromarkerD can outperformed the current tests used to predicting the onset of diabetic kidney disease during a four-year follow-up period.

“The company says it will continue to invest in its biomarker discovery program centred on the Promarker™ technology platform.

Article: Proteomics International Laboratories (ASX:PIQ) receives $1.2 million R&D incentive

Subscribe
  • This field is for validation purposes and should be left unchanged.